- Home
- GROV vs CTOR Comparison
GROV vs CTOR Comparison
Compare GROV & CTOR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GROV
- CTOR
- Stock Information
- Founded
- GROV 2016
- CTOR 2021
- Country
- GROV United States
- CTOR United States
- Employees
- GROV N/A
- CTOR N/A
- Industry
- GROV Package Goods/Cosmetics
- CTOR
- Sector
- GROV Consumer Discretionary
- CTOR
- Exchange
- GROV Nasdaq
- CTOR NYSE
- Market Cap
- GROV 53.5M
- CTOR 63.7M
- IPO Year
- GROV N/A
- CTOR N/A
- Fundamental
- Price
- GROV $1.19
- CTOR $5.30
- Analyst Decision
- GROV Hold
- CTOR Buy
- Analyst Count
- GROV 1
- CTOR 2
- Target Price
- GROV $1.20
- CTOR $6.00
- AVG Volume (30 Days)
- GROV 76.6K
- CTOR 3.3M
- Earning Date
- GROV 08-07-2025
- CTOR 08-11-2025
- Dividend Yield
- GROV N/A
- CTOR N/A
- EPS Growth
- GROV N/A
- CTOR N/A
- EPS
- GROV N/A
- CTOR N/A
- Revenue
- GROV $193,427,000.00
- CTOR N/A
- Revenue This Year
- GROV N/A
- CTOR N/A
- Revenue Next Year
- GROV $6.22
- CTOR N/A
- P/E Ratio
- GROV N/A
- CTOR N/A
- Revenue Growth
- GROV N/A
- CTOR N/A
- 52 Week Low
- GROV $1.02
- CTOR $0.55
- 52 Week High
- GROV $1.95
- CTOR $49.00
- Technical
- Relative Strength Index (RSI)
- GROV 51.35
- CTOR N/A
- Support Level
- GROV $1.10
- CTOR N/A
- Resistance Level
- GROV $1.19
- CTOR N/A
- Average True Range (ATR)
- GROV 0.07
- CTOR 0.00
- MACD
- GROV 0.01
- CTOR 0.00
- Stochastic Oscillator
- GROV 82.05
- CTOR 0.00
About GROV Grove Collaborative Holdings Inc.
Grove Collaborative Holdings Inc is engaged in providing consumer products. It offers Cleaning accessories, Home and Pantry, Personal care products, Pets supplements and Other products. It is a sustainability oriented consumer products generator. It use connection with consumers to create and curate authentic, disruptive brands and products. Company builds natural products that perform as well as, many consumer packaged goods (CPG) brands (both conventional and natural), while being healthier for consumers and the planet.
About CTOR CITIUS ONCOLOGY INC
Citius Oncology Inc is a specialty pharmaceutical company dedicated to the development and commercialization of critical care products targeting unmet needs with a focus on oncology products. In addition, Citius completed enrollment in its Phase 2b trial of CITI-002 (Halo-Lido), a topical formulation for the relief of hemorrhoids.